Clinical Trial Update: Atezolizumab + Pertuzumab + Trastuzumab In CNS Mets In BC [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update investigating the triple combination of atezolizumab, pertuzumab, and trastuzumab for HER2-positive metastatic breast cancer with …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Central Nervous System Metastases

Drugs mentioned

• HERCEPTIN (trastuzumab)
• Perjeta (pertuzumab)
• Tecentriq (atezolizumab)

Snippet

Sponsor: Nancy Lin, MD | Conditions: HER2-positive Metastatic Breast Cancer, Central Nervous System Metastases | Phase 2 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2024-05-07